Search results
Results from the WOW.Com Content Network
The Portfolio Diet is a therapeutic plant-based diet created by British researcher David J. Jenkins in 2003 to lower blood cholesterol. [1] [2] The diet emphasizes using a portfolio of foods or food components that have been found to associate with cholesterol lowering to enhance this effect.
Canada's Food Guide (French: Guide alimentaire canadien) is a nutrition guide produced by Health Canada. In 2007, it was reported to be the second most requested Canadian government publication, behind the Income Tax Forms. [1] The Health Canada website states: "Food guides are basic education tools that are designed to help people follow a ...
The ADA-ACC consensus statement establishes measurement and treatment guidelines for Apolipoprotein B|apoB in addition to LDL and non-HDL in high-risk patients. The VAP test was the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for LDL measurement.
Guidelines by the American College of Cardiology and the American Heart Association recommend statin treatment for primary prevention of cardiovascular disease in adults with LDL cholesterol ≥ 190 mg/dL (4.9 mmol/L) or those with diabetes, age 40–75 with LDL-C 70–190 mg/dL (1.8–4.9 mmol/dL); or in those with a 10-year risk of developing ...
Packaging date: the date a food is placed into a package for the first time for resale to a consumer; or the date a prepackaged product is weighed by a retailer in a package in which it will be offered for sale. [24] Storage instructions: How a product should be stored. Can include temperature, humidity, and light conditions. [24]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
A lipid profile or lipid panel is a panel of blood tests used to find abnormalities in blood lipid ( such as cholesterol and triglycerides) concentrations. [not verified in body] The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases.
Rosuvastatin is approved in the United States for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia), and/or triglycerides (hypertriglyceridemia). [41] In February 2010, rosuvastatin was approved by the FDA for the primary prevention of cardiovascular events.